Literature DB >> 8311114

c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.

Z H Li1, J Zheng, L M Weiss, D Shibata.   

Abstract

The topographical distribution of a mutation provides insight into past patterns of tumor evolution. This approach was applied to two loci commonly mutated in adenocarcinoma of the lung--p53 and c-K-ras. In 41 primary adenocarcinomas, c-K-ras codon 12 point mutations were detected in 8 (19.5%) tumors and p53 point mutations were detected in 10 (24.4%) tumors, with one tumor harboring both mutations. These mutations were only detected in malignant cells and with a homogeneous topographical distribution throughout 16 tumors, including metastasis. Intratumor heterogeneity was detected in only one tumor in which a small portion lacked the specific p53 mutation. Based on this topographical analysis, it is likely that when these mutations occur in adenocarcinoma of the lung, they are usually acquired during the very earliest phases of tumor formation before the bulk of clonal expansion, and in very small precursor lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311114      PMCID: PMC1887136     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.

Authors:  C H Hensel; R H Xiang; A Y Sakaguchi; S L Naylor
Journal:  Oncogene       Date:  1991-06       Impact factor: 9.867

2.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

Authors:  R J Slebos; R E Kibbelaar; O Dalesio; A Kooistra; J Stam; C J Meijer; S S Wagenaar; R G Vanderschueren; N van Zandwijk; W J Mooi
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

3.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

Authors:  S Rodenhuis; M L van de Wetering; W J Mooi; S G Evers; N van Zandwijk; J L Bos
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

5.  ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.

Authors:  T Mitsudomi; S M Steinberg; H K Oie; J L Mulshine; R Phelps; J Viallet; H Pass; J D Minna; A F Gazdar
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

6.  K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.

Authors:  W H Westra; R J Slebos; G J Offerhaus; S N Goodman; S G Evers; T W Kensler; F B Askin; S Rodenhuis; R H Hruban
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

7.  Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

Authors:  K H Vähäkangas; J M Samet; R A Metcalf; J A Welsh; W P Bennett; D P Lane; C C Harris
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

8.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

Authors:  T Mitsudomi; S M Steinberg; M M Nau; D Carbone; D D'Amico; S Bodner; H K Oie; R I Linnoila; J L Mulshine; J D Minna
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

9.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

10.  p53 mutations in human lung tumors.

Authors:  C W Miller; K Simon; A Aslo; K Kok; J Yokota; C H Buys; M Terada; H P Koeffler
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

View more
  29 in total

1.  Tumor extension and cell proliferation in adenocarcinomas of the lung.

Authors:  M Shoji; Y Dobashi; S Morinaga; S X Jiang; T Kameya
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 2.  New prognostic factors in resectable non-small cell lung cancer.

Authors:  E F Smit; H J Groen; T A Splinter; T Ebels; P E Postmus
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 3.  Stage-specific gene expression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Cancer-prone mice expressing the Ki-rasG12C gene show increased lung carcinogenesis after CT screening exposures.

Authors:  Michael T Munley; Joseph E Moore; Matthew C Walb; Scott P Isom; John D Olson; J Gregory Zora; Nancy D Kock; Kenneth T Wheeler; Mark Steven Miller
Journal:  Radiat Res       Date:  2011-09-30       Impact factor: 2.841

5.  Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.

Authors:  Akira Nakamizo; Takanori Inamura; Kiyonobu Ikezaki; Koji Yoshimoto; Satoshi Inoha; Masahiro Mizoguchi; Toshiyuki Amano; Masashi Fukui
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors.

Authors:  Stephanie T Dance-Barnes; Nancy D Kock; Heather S Floyd; Joseph E Moore; Libyadda J Mosley; Ralph B D'Agostino; Mark J Pettenati; Mark Steven Miller
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-27       Impact factor: 4.219

7.  A technique for murine irradiation in a controlled gas environment.

Authors:  M C Walb; J E Moore; A Attia; K T Wheeler; M S Miller; M T Munley
Journal:  Biomed Sci Instrum       Date:  2012

8.  Patterns of p53 mutations in squamous cell carcinoma of the lung. Acquisition at a relatively early age.

Authors:  J Zheng; Q Shu; Z H Li; J I Tsao; L M Weiss; D Shibata
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

Authors:  H Kitamura; Y Kameda; N Nakamura; Y Nakatani; Y Inayama; M Iida; K Noda; N Ogawa; T Shibagaki; M Kanisawa
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 10.  Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).

Authors:  Mudit Vaid; Joanna Floros
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.